Firms
Longitude Capital
- Founded
- —
- Type
- Venture capital
Funds0
No funds on record yet.
Team
No team members on record yet.
Co-investing
Bain Capital
Rivus Pharmaceuticals$132M · 2022-09-22Rivus Pharma$132M · 2022
Amunix Pharmaceuticals$117M · 2021-03-04
Amunix$117M · 2021-03-04
Aptinyx$70M · 2017-12-18
Kestra Medical Technologies$— · Unknown date
Lightspeed
Alpha-9$175M · 2024-10-23Alpha-9 Oncology, Inc.$175M · 2024-10-23
Alpha-9 Oncology$175M · 2024-10-23Alpha-9 Oncology, Inc.$175M · 2024
NxStage Medical$20M · 2004-09-30
Adams Street Partners
Epirium Bio$85M · 2019-12-18
Epirium Bio$85M · 2019
Aptinyx$70M · 2017-12-18NxStage Medical$20M · 2004-09-30
Delos Capital
Alpha-9$175M · 2024-10-23Alpha-9 Oncology, Inc.$175M · 2024-10-23
Alpha-9 Oncology$175M · 2024-10-23Alpha-9 Oncology, Inc.$175M · 2024
General Catalyst
Alpha-9$175M · 2024-10-23Alpha-9 Oncology, Inc.$175M · 2024-10-23
Alpha-9 Oncology$175M · 2024-10-23Alpha-9 Oncology, Inc.$175M · 2024
Frazier Life Sciences
Alpha-9$175M · 2024-10-23Alpha-9 Oncology, Inc.$175M · 2024-10-23
Alpha-9 Oncology, Inc.$175M · 2024
Nextech Invest
Alpha-9$175M · 2024-10-23Alpha-9 Oncology, Inc.$175M · 2024-10-23
Alpha-9 Oncology, Inc.$175M · 2024
Samsara BioCapital
Alpha-9$175M · 2024-10-23Alpha-9 Oncology, Inc.$175M · 2024-10-23
Alpha-9 Oncology, Inc.$175M · 2024
Agent Capital
Alpha-9 Oncology$175M · 2024-10-23
Aptinyx$70M · 2017-12-18
ARCH Venture Partners
Epirium Bio$85M · 2019-12-18
Epirium Bio$85M · 2019
Bluebird Ventures
Epirium Bio$85M · 2019-12-18
Epirium Bio$85M · 2019
Casdin CapitalAmunix Pharmaceuticals$117M · 2021-03-04
Amunix$117M · 2021-03-04
Franklin Templeton
Amunix Pharmaceuticals$117M · 2021-03-04
Amunix$117M · 2021-03-04
Medicxi
Rivus Pharmaceuticals$132M · 2022-09-22Rivus Pharma$132M · 2022
RA Capital Management
Rivus Pharmaceuticals$132M · 2022-09-22Rivus Pharma$132M · 2022
Venrock
Amunix Pharmaceuticals$117M · 2021-03-04
Amunix$117M · 2021-03-04
Vertex Ventures HC
Epirium Bio$85M · 2019-12-18
Epirium Bio$85M · 2019
Viking Global Investors
Amunix Pharmaceuticals$117M · 2021-03-04
Amunix$117M · 2021-03-04
Adage Capital Management
Aptinyx$70M · 2017-12-18
Advent Life Sciences
Nalu Medical$85M · 2024-03-05
Andera Partners
Kestra Medical Technologies$— · Unknown date
Aperture Venture Partners
Nalu Medical$85M · 2024-03-05
Atlas Venture
NxStage Medical$20M · 2004-09-30
B Capital
Nalu Medical$85M · 2024-03-05
BVF Partners L.P.
Alpha-9 Oncology$175M · 2024-10-23
Cormorant Asset Management
Epirium Bio$85M · 2019-12-18
Decheng Capital
Nalu Medical$85M · 2024-03-05
Endeavour Vision
Nalu Medical$85M · 2024-03-05
Eventide Asset Management
Kestra Medical Technologies$— · Unknown date
Gilde Healthcare
Nalu Medical$85M · 2024-03-05
Illumina Ventures
Alpha-9 Oncology$175M · 2024-10-23
Longitude
Nalu Medical$85M · 2024-03-05
Marubeni Corporation
NxStage Medical$20M · 2004-09-30
MVM Partners
Nalu Medical$85M · 2024-03-05
New Leaf Venture Partners
Aptinyx$70M · 2017-12-18
Novo Holdings
Nalu Medical$85M · 2024-03-05
Omega Funds
Kestra Medical Technologies$— · Unknown date
Osage University Partners
Aptinyx$70M · 2017-12-18
Pura Vida Investments
Nalu Medical$85M · 2024-03-05
T. Rowe Price
Kestra Medical Technologies$— · Unknown date
The Longevity Fund
Epirium Bio$85M · 2019
Wasatch
NxStage Medical$20M · 2004-09-30